Edwards Lifesciences Corp EW
Orthopedic, Prosthetic & Surgical Appliances & Supplies ยท NYSE
์์ต
$5.01B
+12.2% ๋
๋๋
๋
์์์ต
$1.40B
-7.9% ๋
๋๋
๋
์ด ์์ฐ
$13.06B
+39.4% ๋
๋๋
๋
EPS
2.30
-5.7% ๋
๋๋
๋
Advertisement
Income Statement
| ๊ธฐ๊ฐ | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Revenues | $2.94B | $1.41B | $5.01B | $4.05B | $2.70B | $1.33B | $4.46B | $3.74B |
| Gross Profit | $2.30B | $1.11B | $4.03B | $3.23B | $2.14B | $1.04B | $3.74B | $3.02B |
| R&D Expense | $530.80M | $254.60M | $962.90M | $781.90M | $528.50M | $256.70M | $843.60M | $720.80M |
| SG&A Expense | $967.70M | $465.70M | $1.58B | $1.30B | $875.90M | $428.40M | $1.36B | $1.17B |
| Operating Income (Loss) | $806.00M | $394.80M | $1.31B | $1.07B | $715.50M | $349.00M | $1.50B | $962.10M |
| Interest Expense | โ | โ | โ | โ | โ | โ | โ | โ |
| Net Income (Loss) | $691.20M | $358.00M | $1.40B | $3.79B | $718.20M | $351.90M | $1.52B | $1.03B |
| EPS (Diluted) | 1.18 | 0.61 | 2.30 | 6.29 | 1.19 | 0.58 | 2.44 | 1.69 |
์ฌ๋ฌดํ
| ๊ธฐ๊ฐ | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.70B | $13.70B | $13.06B | $13.06B | $13.06B | $13.06B | $9.36B | $9.36B |
| Current Assets | $6.74B | $6.74B | $6.29B | $6.29B | $6.29B | $6.29B | $4.04B | $4.04B |
| Cash & Equivalents | $2.94B | $2.94B | $3.05B | $3.05B | $3.05B | $3.05B | $1.13B | $1.13B |
| Accounts Receivable | $659.60M | $659.60M | $609.10M | $609.10M | $609.10M | $609.10M | $771.50M | $771.50M |
| Inventory | $1.13B | $1.13B | $1.09B | $1.09B | $1.09B | $1.09B | $903.50M | $903.50M |
| PP&E (Net) | $1.81B | $1.81B | $1.69B | $1.69B | $1.69B | $1.69B | $1.59B | $1.59B |
| Goodwill | $1.77B | $1.77B | $1.15B | $1.78B | $1.78B | $1.78B | $1.06B | $1.15B |
| Total Liabilities | $3.36B | $3.36B | $2.99B | $2.99B | $2.99B | $2.99B | $2.64B | $2.64B |
| Current Liabilities | $1.81B | $1.81B | $1.51B | $1.51B | $1.51B | $1.51B | $1.20B | $1.20B |
| Accounts Payable | $227.50M | $227.50M | $197.40M | $197.40M | $197.40M | $197.40M | $186.60M | $186.60M |
| Long-Term Debt | โ | โ | โ | โ | โ | โ | โ | โ |
| Stockholders Equity | $10.34B | $10.34B | $10.00B | $10.00B | $10.00B | $10.00B | $6.65B | $6.65B |
Cash Flow Statement
| ๊ธฐ๊ฐ | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $570.60M | $280.40M | $895.80M | $669.80M | $318.00M | $-53.50M | $1.22B | $759.20M |
| Investing Cash Flow | $-86.80M | $85.30M | $173.80M | $2.89B | $187.90M | $63.10M | $252.30M | $159.70M |
| Financing Cash Flow | $-205.30M | $-258.00M | $-711.00M | $-1.01B | $-34.90M | $61.70M | $-1.58B | $-297.80M |
| Stock Repurchases | $264.10M | $258.60M | $879.60M | $1.06B | $158.30M | $200.00K | $1.73B | $431.20M |
์ ์ฌ ๊ธฐ์
๋ ์์๋ณด๊ธฐ
How to Find Any SEC Filing in Two MinutesCash-Flow Quality: Profit Is an Opinion, Cash Is a FactValuation Basics: P/E, P/S and What They Actually Tell YouDividends: How Companies Pay Shareholders and How to Read ThemHow to Read a 10-K Annual Report (Without Falling Asleep)Understanding Earnings Per Share (EPS)How to Read a Cash Flow StatementHow to Read a Balance SheetHow to Read an Income Statement
๋ฐ์ดํฐ๋ ๋ฏธ๊ตญ SEC EDGAR ๊ณต๊ณต ๋ฐ์ดํฐ๋ฒ ์ด์ค์์ ์์ง๋์์ต๋๋ค. ์ด ์ฌ์ดํธ๋ ํฌ์ ์กฐ์ธ์ ์ ๊ณตํ์ง ์์ต๋๋ค.